Topic Listing for STAAR Surgical Company

Accounts Receivable Trade Accounts Receivable Trade Net
Acquisition Remaining Interests Japanese Joint Venture Activities Involve Hazardous Materials Emissions Subject Environmental Liability
Addendum Additional Information
Adopted Pursuant 906 Sarbanes-oxley Act 2002 Amendment
Amendments Articles Incorporation Bylaws Change Amendments Registrants Code Ethics Waiver Provision
Announces Cost Saving Strategies Address Liquidity Issuescompany Exploring Annual Report Form 10-k
Anti-takeover Provisions Delaware Law Delay Prevent Acquisition Applications Proceeds
Approval Icl Audit Committee
Background Backlog
Barry Caldwell Barry Caldwell President Chief Executive Officer
Basic Diluted Loss Per Share Basis Presentation
Basis Presentation Significant Accounting Policies Benefits
Binding Agreement Assignment Board Directors Recommends Vote Election Nominees
Bylaws Contain Other Provisions Anti-takeover Effect Including Following Canon Staar Joint Venture
Cash Equivalents Certain Definitions
Certain Relationships Related Transactions Certificate Incorporation Delay Prevent Acquisition Sale
Certification Certification Pursuant Usc 1350
Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act Certifications
Changes Accounting Standards Affect Financial Results Changes Internal Control Over Financial Reporting
Changes Reimbursement Products Third-party Payors Reduce Sales Make Charles Kaufman Named Newly Created Position General Counsel
Charter Documents Contractual Obligations Delay Prevent Acquisition Sale Charter Documents Delay Prevent Acquisition Sale
Charters Committees Chief Financial Officer
Code Ethics Collateral
Commitments Contingencies Committees
Common Stock Compared 2005
Comparison Five-year Cumulative Total Returns Compensation Committee
Compensation Committee Interlocks Insider Participation Compensation Committee Report
Compensation Directors Compensation Discussion Analysis
Compensation Program Objectives Rewards Compete Much Larger Companies
Competition Completion Acquisition Disposition Assets
Compliance Exchange Act Comprehensive Loss
Concentration Credit Risk Condensed Consolidated Statements Operations
Conditions Consent Independent Registered Public Accounting Firm
Contingencies Continuing Directors
Contracts Contracts Exhibits Public Reports Contain Recitals Representations Warranties
Contractual Obligations Contractual Restrictions Credit Arrangements
Controls Procedures Copyright License
Copyrights Core Domestic Business Suffered Declining Sales
Core Domestic Business Suffered Declining Sales New Products Costs Arising Agreement
Costs Expenses Counterparts
Credit Facilities Credit Period Withdrawal
Critical Accounting Policies David Bailey President Chief Executive Officer
David Bailey President International Operations David Schlotterbeck
David Schlotterbeck Public Veteran Executive Replaces Retired Board Deborah Andrews
Deborah Andrews Vice President Chief Financial Officer Defined Benefit Pension Plans Currently Underfunded Subject Significant
Defined Contribution Plan Deliveries
Deliveries Investor Demonstration Equipment
Departure Directors Certain Officers Election Appointment Compensatory Departure Directors Principal Officers Election Appointment
Depend Independent Manufacturers Representatives Depend Key Employees
Depend Proprietary Technologies Not Able Protect Intellectual Property Director Compensation
Directors Executive Officers Registrant Disclosure Controls Procedures
Disclosure Requirements Distribution Customers
Documents Incorporated Reference Domilens Gmbh
Donald Duffy Chairman Don Bailey David Morrison Efforts Reverse Decline Cataract Business Shifting Focus
Employee Defined Benefit Plan Employees
Employment Agreements Entire Agreement
Entry Material Definitive Agreement Environmental Matters
Estimates Evaluation Disclosure Controls Procedures
Ex-currency Ex-japan
Exact Name Registrant Specified Charter Executive Compensation
Executive Officers Exhibits
Expansion Board Election New Chairman Expenses
Experience Losses Due Product Liability Claims Explanatory
Face Challenge Successfully Integrating New Japanese Subsidiary Facsimile Signature
Fail Keep Pace Advances Industry Persuade Physicians Adopt Failure Design Maintain Controls Over German Subsidiary Sufficient
Failure Users Products Obtain Adequate Reimbursement Third-party Payors Fair Value Financial Instruments
Fda Approval Toric Icl Significant Market Significantly Delayed Fda Compliance Issues Harmed Reputation Expect Devote Significant
Fda Review Staars Quality Systems Fda Warning Letters Form 483 Observations
Fees Expenses Financial Information Segments Geographic Areas
Financial Statements Exhibits Financial Statements Supplementary Data
Financing Strategy Foreign Currency
Foreign Exchange Form 10-k
Form 10-k Amendment Form 10-q
Forms Often Modified Meet Changing Requirements Law Needs Future Sales Common Stock Reduce Price
Future Success Depends Successful Marketing Icl United States General
General Administrative General Administrative Expenses
General Terms Conditions Business Geographic Product Data
German Distribution Business Global Nature Business Result Fluctuations Declines Sales Profits
Global Nature Business Result Significant Fluctuations Results Operations Goodwill Other Intangible Assets
Governing Law Grant Security Interest
Granting Credit Grants Plan Based Awards 2006
Gross Profit Gross Profit Margin
Guenther Roepstorff Former President Domilens Gmbh Hans Blickensdoerfer Vice President International Marketing
Hazardous Substances History
History Losses Anticipate Future History Losses Limits Access Credit Increases Risk Default
History Staar Human Eye
Impairment Long-lived Assets Important Notice Regarding Availability Proxy Materials
Income Taxes Indemnification
Indemnification Agreements Independent Registered Public Accounting Firm
Independent Registered Public Accounting Firm Report Schedule Index
Inflation Instrument Adherence
Intellectual Property Interest Canon Staar Acquired Book Value Occurrence Specified
Internal Control Over Financial Reporting International Visian Icl Sales Grow Percent
Inventories Investigation Fraud Domilens Gmbh
Investigations Allegations Whether Not They Lead Enforcement Action Investment Joint Venture
Japan Jurisdiction
Key Collateral Lease Line Credit
Lease Obligations Legal Proceedings
Lessees Obligations Lessees Property Business Interruption Insurance
Liability Insurance Licensed Technology Joint Venture Cause Become Competitor
Licensed Technology Joint Venture Granted Certain Rights Partners Licensed Technology Joint Venture Granted Rights Partners Exercised
Limited Ability Fully Recorded Tax Loss Carryforwards Limited Access Credit Default Terms Loan Agreements
Lines Credit Liquidity Capital Resources
Litigation Litigation Claims
Loan Fees Lose Customers Sales Result Restructuring Force Non-renewal Agreements
Loss Per Share Loss Settlement Pre-existing Distribution Arrangement
Lost Sales Result Restructuring Force Discontinuation Arrangements Independent Management Report Internal Control Over Financial Reporting
Market Price Common Stock Likely Volatile Marketing Selling
Marketing Selling Expenses Marks
Meetings Board Most Products Single-site Manufacturing Approvals Exposing Risks Business
Net Loss Per Share Net Sales
Net Sales Surgical Line New Accounting Pronouncements
Nicholas Curtis Senior Vice President Sales Marketing Nominating Governance Committee
Nominees Director Non-gaap Measures
Not Successfully Develop Launch Replacements Products Lose Patent Notes
Notes Payable Notes Receivable Former Directors
Notice Annual Meeting Stockholders Notices
Now Therefore Obligations
Obtain Some Components Products Single Source Interruption Supply Off-balance Sheet Arrangements
Only Limited Access Financing Only Limited Working Capital
Only Limited Working Capital Access Financing Option Exercises Stock Vested Year-end 2006
Option Exercises Stock Vested Year-end 2007 Option Exercises Stock Vested Year-end 2009
Organization Description Business Other Charges
Other Current Liabilities Other Events
Other Expense Other Expense Income Net
Other Highlights Other Income Expense Net
Other Information Other Information Not Applicable Exhibits
Other Liabilities Other Products
Other Recent Highlights Other Security
Overdraft Limit Amount Overview
Part Part Financial Information
Part Other Information Patent License
Patents Patents Trademarks Licenses
Paul Hambrick Vice President Operations Payable
Payment Premium Increases Pension Benefits 2007
Pension Benefits 2009 Performance Against Objectives
Person8221 Plan
Prepaids Deposits Other Current Assets President Chief Executive Officer
Primary Strategy Restore Profitability Been Penetrate Refractive Market Principal Accountant Fees Services
Principal Products Principal Subsidiaries
Prior Reclassifications Private Placements
Product History Product Recalls Been Costly Future
Properties Property Lnsurance Building Improvements Rental Value
Property Plant Equipment Proposal Election Directors
Prospectus8221 Proxy Statement Annual Meeting Stockholders Held 2009
Proxy Statement Pursuant Securities Exchange Act 1934 Amendment Public Equity Offering
Purchase Common Stock Purchasers Certificate Subsequent Sale
Pursuant Securities Exchange Act 1934 Quantitative Qualitative Disclosures Market Risk
Quarterly Financial Data Ratification Registered Public Accounting Firm
Receivables Former Directors Receivables Officers Directors
Recent Accounting Pronouncements Recent Correspondence Fda Regarding Clinical Oversight Ticl Approval
Recent Proceedings Fda Office Compliance Reclassifications
Registrants Telephone Number Including Area Code Registration Statement
Registration Statement8221 Regulation Disclosure
Regulatory Investigations Allegations Whether Not They Lead Enforcement Regulatory Matters
Regulatory Requirements Reinhard Pichl Managing Director Domilens Gmbh
Related Party Transactions Remediation Material Weakness Internal Control Over Financial Reporting
Remediation Material Weakness Regarding Control Over German Subsidiary Rent
Report Audit Committee Report Schedule
Research Development Research Development Costs
Research Development Expenses Reserves Reversals
Resources Devoted Research Development Not Yield New Products Responsibility Collateral
Restatement Restricted Cash
Restricted Cash Short-term Investments Results Operations
Results Operations Financial Condition Revenue Recognition
Revenues Review Related Person Transactions
Rights Remedies Default Risk Factors
Risk Losses Through Litigation Risks Related Ophthalmic Products Industry
Risks Related Ownership Common Stock Safe Harbor
Sales Sales Subject Significant Seasonal Variation
Schedule Seal Signature Borrower
Seasonality Security
Security Interest Security Interest Absolute
Security Ownership Certain Beneficial Owners Management Related Stockholder Segment Reporting
Senior Secured Several Borrowers
Share-based Payments Shares
Ship 3-piece Collamer Injector System Short-term Investments Restricted
Short-term Investments-restricted Signatures
Significant Adjustments Significant Factors Affecting Business Recent Highlights
Significant Subsidiaries Software Intellectual Property
Sources Availability Raw Materials Special Provisions
Staar Surgical Staar Surgical 1911 Walker Avenue Monrovia California 91016
Staar Surgical 2003 Omnibus Equity Incentive Plan Staar Surgical Announces Closing Common Stock Offering
Staar Surgical Appoints New Independent Board Member Staar Surgical Condensed Consolidated Balance Sheet 000s
Staar Surgical Engages Morgan Stanley Explore Strategic Financial Staar Surgical Exact Name Registrant Specified Charter
Staar Surgical Signs Definitive Agreement Sell 4100000 Shares Staar Surgical Subsidiaries Consolidated Financial Statements 2007 2006
Staar Surgical Subsidiaries Report Independent Registered Public Accounting Staars Business Environment
Stock Based Compensation Stock Option Plans
Stock Performance Graph Stock-based Compensation
Stockholder Communications Directors Stockholders Equity
Stockholders Urged Immediately Complete Date Sign Enclosed Proxy Strategy
Strategy Restore Profitability Near Term Relies Successfully Penetrating Strikes Slow-downs Other Job Actions Doctors Reduce Sales
Subject Extensive Government Regulation Increases Costs Prevent Selling Subject International Tax Laws Affect Financial Results
Subject International Taxation Laws Affect Financial Results Subject Limitations Fully Utilizing Recorded Tax Loss Carryforwards
Submission Matters Vote Security Holders Subsequent Event
Subsequent Events Success International Operations Depends Successfully Managing Foreign Subsidiaries
Suffer Loss Facilities Due Catastrophe Operations Seriously Harmed Supplemental Disclosure Cash Flow Information
Supply Agreement Swiss Credit Facility
Table Contents Tax Filings
Term Agreement Termination Material Definitive Agreement
Thomas Paul Head Research Top Form
Trade Secret Trade Secrets
Trademark License Trademarks
Transition Report Pursuant Securities Exchange Act 1934 Ucc
Unable Protect Information Systems Against Data Corruption Cyber-based Unregistered Sales Equity Securities
Via Edgar Transmission Class Mail Warranties Covenants
Whereas Witness Whereof
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki